CSCO 2014:晚期胃癌腹膜转移的处理对策

2014-09-19 廖莉莉 中国医学论坛报

        复发转移性胃癌">胃癌综合治疗论坛(2楼3号会议室)时间:9月20日09:30~10:00         报告者:复旦大学附属中山医院刘天舒 胃癌中腹膜转移约占40%~50%,胃癌腹膜转移自然病程的平均生存时

        复发转移性胃癌">胃癌综合治疗论坛(2楼3号会议室)时间:9月20日09:30~10:00

        报告者:复旦大学附属中山医院刘天舒

胃癌中腹膜转移约占40%~50%,胃癌腹膜转移自然病程的平均生存时间和中位生存时间分别为6.5个月和3.1个月,预后极差,如不予以治疗严重威胁患者生命,但目前为止,并无行之有效的国际认可的标准治疗方案,因此胃癌腹膜转移的诊疗模式值得深入探讨。目前普遍被接受的仍然是Paget提出的“种子——土壤学说”,即单个肿瘤细胞从原发部位脱落,这些游离的肿瘤细胞分散于腹腔液中,肿瘤细胞分泌细胞因子等,引起腹膜发生纤维化等变化,为腹膜转移提供“土壤”,肿瘤细胞与腹膜间皮细胞通过细胞间黏附分子1和CD44等直接相互作用,打开腹膜间皮细胞之间的细胞连接,到达腹膜间皮的细胞外基质,通过整合素等引起基质降解,肿瘤细胞侵袭进入间皮下层,继续浸润性恶性生长。

胃癌细胞脱落至腹腔与胃癌是否侵及胃浆膜及侵犯胃浆膜的面积大小有关。会上,将围绕晚期胃癌腹膜转移的处理对策展开具体论述。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=209563, encodeId=d15d2095638a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 11 23:49:23 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809272, encodeId=34fc18092e293, content=<a href='/topic/show?id=0c7983245d9' target=_blank style='color:#2F92EE;'>#胃癌腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83245, encryptionId=0c7983245d9, topicName=胃癌腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Mon May 18 22:06:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276579, encodeId=76ba12e657952, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59878, encryptionId=59ed598e816, topicName=晚期胃癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578988, encodeId=669315e898887, content=<a href='/topic/show?id=0ff4856621f' target=_blank style='color:#2F92EE;'>#腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85662, encryptionId=0ff4856621f, topicName=腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6d16475304, createdName=新生儿张玉军, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623739, encodeId=fd621623e3927, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]
    2017-06-11 luominglian113

    学习了,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=209563, encodeId=d15d2095638a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 11 23:49:23 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809272, encodeId=34fc18092e293, content=<a href='/topic/show?id=0c7983245d9' target=_blank style='color:#2F92EE;'>#胃癌腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83245, encryptionId=0c7983245d9, topicName=胃癌腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Mon May 18 22:06:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276579, encodeId=76ba12e657952, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59878, encryptionId=59ed598e816, topicName=晚期胃癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578988, encodeId=669315e898887, content=<a href='/topic/show?id=0ff4856621f' target=_blank style='color:#2F92EE;'>#腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85662, encryptionId=0ff4856621f, topicName=腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6d16475304, createdName=新生儿张玉军, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623739, encodeId=fd621623e3927, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=209563, encodeId=d15d2095638a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 11 23:49:23 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809272, encodeId=34fc18092e293, content=<a href='/topic/show?id=0c7983245d9' target=_blank style='color:#2F92EE;'>#胃癌腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83245, encryptionId=0c7983245d9, topicName=胃癌腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Mon May 18 22:06:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276579, encodeId=76ba12e657952, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59878, encryptionId=59ed598e816, topicName=晚期胃癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578988, encodeId=669315e898887, content=<a href='/topic/show?id=0ff4856621f' target=_blank style='color:#2F92EE;'>#腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85662, encryptionId=0ff4856621f, topicName=腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6d16475304, createdName=新生儿张玉军, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623739, encodeId=fd621623e3927, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=209563, encodeId=d15d2095638a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 11 23:49:23 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809272, encodeId=34fc18092e293, content=<a href='/topic/show?id=0c7983245d9' target=_blank style='color:#2F92EE;'>#胃癌腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83245, encryptionId=0c7983245d9, topicName=胃癌腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Mon May 18 22:06:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276579, encodeId=76ba12e657952, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59878, encryptionId=59ed598e816, topicName=晚期胃癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578988, encodeId=669315e898887, content=<a href='/topic/show?id=0ff4856621f' target=_blank style='color:#2F92EE;'>#腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85662, encryptionId=0ff4856621f, topicName=腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6d16475304, createdName=新生儿张玉军, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623739, encodeId=fd621623e3927, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=209563, encodeId=d15d2095638a, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 11 23:49:23 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809272, encodeId=34fc18092e293, content=<a href='/topic/show?id=0c7983245d9' target=_blank style='color:#2F92EE;'>#胃癌腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83245, encryptionId=0c7983245d9, topicName=胃癌腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Mon May 18 22:06:00 CST 2015, time=2015-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276579, encodeId=76ba12e657952, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59878, encryptionId=59ed598e816, topicName=晚期胃癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578988, encodeId=669315e898887, content=<a href='/topic/show?id=0ff4856621f' target=_blank style='color:#2F92EE;'>#腹膜转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85662, encryptionId=0ff4856621f, topicName=腹膜转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e6d16475304, createdName=新生儿张玉军, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623739, encodeId=fd621623e3927, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Sun Sep 21 00:06:00 CST 2014, time=2014-09-21, status=1, ipAttribution=)]
    2014-09-21 xuyong530

相关资讯

CSCO 2014:肺癌个体化治疗时代的检测变革

非小细胞肺癌论坛(1楼1E会议室)时间:9月19日10:55~11:15 报告者:北京大学肿瘤医院  王洁 对肺癌驱动基因的深入研究导致了基因检测的巨大变革,肺癌驱动基因的检测正在经历从单基因到多基因、从静态到动态、从定性到定量、从组织水平到单细胞水平的变革。随着组织病理学到分子病理学的发展,NSCLC不再被认为是一个疾病而是由不同驱动基因作用的一组疾病。检测技术的变革已经并将继

CSCO 2014:局部进展期胃癌放化疗的是与非

复发转移性胃癌">胃癌综合治疗论坛(2楼3号会议室)时间:9月20日11:30~11:45 报告者:中山大学附属第一医院彭建军 我国是胃癌大国,每年大约有40万新发病例及30万死亡病例。在接受手术的患者中,约91%胃癌患者死于术后复发。胃癌复发有多种方式,分为局部复发、肝转移复发、肝转移以外的血行转移性复发、腹膜播种、淋巴结转移复发、其他等6种,其局部(手术野)复发和残胃复发合称为局部复

CSCO 2014:R0切除术在胃癌肝转移患者中的应用和进展

        复发转移性胃癌">胃癌综合治疗论坛(2楼3号会议室)时间:9月20日10:30~10:45         报告者:天津医科大学附属肿瘤医院黄鼎智 近期统计数据揭示中国胃癌发病率为第2位(36.21例/10万人

CSCO 2014:中国学者须重视临床研究数据标准

        临床研究中的数据标准及监管要求论坛策划负责人、北京大学肿瘤医院 朱军 双管齐下,促进临床研究标准化 此次“临床研究中的数据标准及监管要求”论坛主要有两个目的:一是使临床医生对临床药监部门在监管方面有何法规或政策性的特殊要求有所掌握和理解;二是对临床研究工作者进行临床数据标准的继续培训。 在实际

CSCO 2014:EGFR基因突变状态未知NSCLC治疗——TKIor化疗?

非小细胞肺癌论坛(1楼1E会议室)时间:9月19日11:45~12:00 报告者:南军事医学科学院附属医院  刘晓晴 目前非小细胞肺癌依据驱动基因EGFR突变状态分为EGFR突变型、EGFR野生型和EGFR状态未知型,在个体化治疗理念主导的当今,临床实践必须依据其EGFR基因状态选择治疗。  在分子生物学指标指导下的个体化治疗时代,我们依然不能抛开患者的临床病理特点而

CSCO 2014:晚期胃癌姑息手术外科观

        复发转移性胃癌">胃癌综合治疗论坛(2楼3号会议室)时间:9月20日10:45~11:00         报告者:北京大学肿瘤医院李子禹 胃癌为全球最常见恶性肿瘤之一,在我国其患病率居恶性肿瘤第2位,而死亡率